10-K: Palladyne AI Pivots to Software, Reports Net Income Amid Acquisitions
Annual Report
Palladyne AI Corp. reported a net income of $10.0 million for 2025, a significant improvement from the prior year's loss, driven by non-cash gains and strategic acquisitions despite a decline in revenue and increased operational losses.
Summary
- Palladyne AI Corp. (PDYN) is a U.S.-based technology company developing embodied AI software and collaborative autonomy solutions, advanced avionics, UAVs, engineering services, and precision-manufactured components for defense and commercial/industrial markets.
- The company pivoted its business strategy on November 14, 2023, to prioritize AI/ML Foundational Technology and suspend further commercialization efforts on hardware robotics products, changing its name to Palladyne AI Corp. on March 18, 2024.
- Key AI software offerings include Palladyne IQ, SwarmOS, and Palladyne Pilot, designed to be hardware agnostic and operate 'on the edge' without cloud or large-language model (LLM) reliance.
- On November 14, 2025, Palladyne AI acquired GuideTech, LLC (engineering), MKR Fabrication, LLC (fabrication), and Warnke Precision Machining, LLC (precision machining) to offer vertically integrated solutions.
- The company launched Palladyne IQ 2.0 and secured its first paid customer for this product.
- Palladyne AI is developing drone munitions platforms, Gremlin-X and SwarmStrike, both of which have been successfully test-flown.
- Revenue for the year ended December 31, 2025, was $5.2 million, a 33% decrease from $7.8 million in 2024, primarily due to the discontinuation of legacy hardware product sales.
- The company reported a net income of $10.0 million for 2025, a substantial improvement from a net loss of $72.6 million in 2024, largely due to a $37.7 million gain on warrant liabilities and a $2.5 million income tax benefit.
- Loss from operations increased to $32.4 million in 2025 from $26.9 million in 2024.
- Net cash used in operating activities increased to $27.6 million in 2025 from $22.6 million in 2024.
- The company raised approximately $68.9 million in gross proceeds from the sale of Common Stock and warrants during Q4 2024 and fiscal year 2025, including $30.0 million from an 'at-the-market' equity offering in 2025 and $7.5 million from another ATM offering by December 31, 2025.
- As of December 31, 2025, cash, cash equivalents, and marketable securities totaled $47.1 million, and total stockholders' equity was $74.7 million, a significant improvement from a $9.5 million deficit in 2024.
- The company's backlog as of December 31, 2025, was $13.9 million, with a total estimated contract value of $20.0 million.
Sentiment
Score: 4
Explanation: StockSavvy.ai views this filing with cautious optimism. While the company achieved a net income and significantly improved its equity position, these gains are largely non-operational. Core business metrics like revenue and operating loss show deterioration, indicating ongoing challenges in commercializing its new AI-focused strategy, despite strategic acquisitions and successful capital raises.
Positives
- Net income significantly improved to $10.0 million in 2025 from a net loss of $72.6 million in 2024.
- Total stockholders' equity shifted from a deficit of $9.5 million in 2024 to a positive $74.7 million in 2025.
- Warrant liabilities decreased substantially to $2.8 million in 2025 from $51.4 million in 2024, contributing a $37.7 million gain.
- Strategic acquisitions of GuideTech, Warnke Precision Machining, and MKR Fabricators in November 2025 expanded engineering, avionics, and manufacturing capabilities, supporting a vertically integrated solution strategy.
- Successful test flights of proprietary drone munitions platforms, Gremlin-X and SwarmStrike, demonstrate progress in product development.
- The launch of Palladyne IQ 2.0 and securing the first paid customer for this product marks initial commercialization success for the new AI software focus.
- The company believes it has sufficient liquidity to operate for at least the next 12 months from the filing date, supported by recent capital raises.
- An income tax benefit of $2.5 million was recognized in 2025 due to the removal of a portion of the valuation allowance on net deferred tax assets following acquisitions.
Negatives
- Revenue decreased by 33% from $7.8 million in 2024 to $5.2 million in 2025, primarily due to the discontinuation of legacy hardware product sales.
- Loss from operations increased to $32.4 million in 2025 from $26.9 million in 2024, indicating worsening core operational performance.
- Net cash used in operating activities increased to $27.6 million in 2025 from $22.6 million in 2024, reflecting higher cash burn.
- The company has a history of losses and expects to incur significant losses for the foreseeable future.
- Commercialization of core AI products is in early stages with unproven market demand and potentially long sales cycles (12-18 months for Palladyne IQ, unknown for others).
- The company has no or limited previous history with commercializing its new software products and was unsuccessful with legacy hardware technologies.
- Significant capital is required for business plans, and future financing may dilute stockholders or introduce restrictive covenants.
Risks
- The company is an early-stage company with a history of losses and expects to incur significant losses for the foreseeable future.
- Operating and financial projections rely on management assumptions and analyses that may prove incorrect, leading to materially different actual results.
- The company has yet to achieve positive operating cash flow, and its ability to generate positive cash flow is uncertain.
- There is no or limited previous history or experience with commercializing products, and past efforts with legacy hardware were unsuccessful.
- Issues in the development and use of AI/ML Foundational Technology or AI-enabled products, or issues in products developed by others, may result in reputational harm or liability.
- AI/ML Foundational Technology and other products are new, and customer trials and discussions may not result in purchases.
- If the company cannot generate material revenues from products and services before exhausting financial resources, it may need to cease business operations.
- Failure to attract or retain customers at sufficient rates or in sufficient numbers or at all is a risk.
- The company has no previous history with its licensing sales model for software products.
- Important assumptions about market demand, pricing, adoption rates, and sales cycles for products and services may be inaccurate.
- The benefits of AI/ML Foundational Technology and related products to customers and projected return on investment have not been substantiated through customer use.
- Targeting large businesses, including government prime contractors, with substantial negotiating power and potentially competitive internal solutions poses a risk.
- A portion of revenue is currently and will continue to be generated by contracts with government entities, which makes the company subject to uncertainties, challenges, and risks, including government shutdowns.
- The company operates in a competitive industry subject to rapid technological change, and competition is expected to increase; products may not be competitive.
- Inability to successfully enhance product offerings through research and development efforts is a risk.
- Real or perceived design flaws, errors, defects, glitches, bugs, or malfunctions in technologies, products, and services, or user errors, can result in lower than expected return on investment, personal injury, property damage, and significant security or safety concerns.
- The use of 'open source' software could negatively affect the ability to offer technologies and products and subject the company to possible litigation.
- Business and prospects depend significantly on the ability to build brands; negative publicity could harm brands and reputation.
- Management team has broad discretion, and past decisions have not always led to desired results; current and future decisions may not be successful or may have unintended consequences.
- Failure to effectively manage the business may hinder successful development, marketing, and commercialization of technologies and products.
- Inability to adequately control costs associated with operations to achieve profitability is a risk.
- Substantial research and development costs are expected, and the company may never reach profitability or achieve significant licensing revenue.
- Some products require hardware components, and dependence on single, sole, or limited source suppliers could have a material adverse effect.
- Business involves significant risks and uncertainties that may not be covered by indemnity or insurance.
- Risks related to wars, natural disasters, health epidemics, and other calamities and supply chain disruption could significantly disrupt operations.
- Business plans require a significant amount of capital; additional equity or debt sales may dilute stockholders or introduce restrictive covenants. Inability to secure new funding may lead to cessation of operations.
- Financial results may vary significantly from period to period due to fluctuations in operating costs, revenues, product demand, and other factors.
- High dependence on senior management and other key employees; inability to attract, integrate, and retain qualified employees could harm the ability to develop and commercialize technologies and products.
- Failure to maintain and strengthen effective systems of disclosure controls and procedures and internal control over financial reporting could adversely affect timely and accurate financial statements or compliance.
- Risks associated with strategic relationships, acquisitions, or transactions; inability to identify or form desired strategic relationships in the future.
- Manufacturing or engineering processes and services non-compliance with regulatory requirements, or manufacturing/designing defective products, could decline demand and lead to liability claims.
- Changes in tax laws could have a material adverse effect on business, cash flows, results of operations, or financial condition.
- New or changing governmental regulations relating to design, manufacturing, development, marketing, licensing, distribution, or use of technology and products, or customer service, or transactions with foreign entities, could lead to delays, withdrawal of products, increased costs, or make the business unviable.
- Subject to claims, lawsuits, arbitration proceedings, government investigations, and other legal, regulatory, and administrative proceedings and potential liability and expenses.
- Subject to evolving laws, regulations, standards, policies, and contractual obligations related to data privacy and security; actual or perceived failure to comply could harm reputation, subject to fines and liability.
- Subject to cybersecurity risks to operational systems, security systems, infrastructure, and data.
- Subject to laws, regulations, and contractual provisions as a government contractor and subcontractor, including cybersecurity requirements like CMMC.
- Subject to U.S. and foreign anti-corruption and anti-money laundering laws and regulations.
- Subject to governmental export and import controls and laws that could subject the company to liability.
- Increased scrutiny and changing expectations from regulators, investors, customers, employees, and others regarding environmental, social, and governance (ESG) practices and reporting.
- Success depends in part on the ability to obtain and maintain protection for intellectual property; patent positions covering software and solutions can be highly uncertain.
- May not be able to effectively protect intellectual property rights in target markets or at all.
- May be subject to intellectual property infringement claims or misappropriation claims, which may be time-consuming and expensive.
- Intellectual property discovered through government-funded programs may be subject to federal regulations such as 'march-in' rights, certain reporting requirements, and a preference for U.S.-based companies.
- May be subject to damages resulting from claims of wrongful use or disclosure of alleged trade secrets of employees' former employers.
- The issuance or sale of shares of Common Stock, or rights to acquire shares, could depress the trading price and cause dilution to existing stockholders.
- The price of Common Stock could decline due to the large number of shares subject to employee equity awards.
- The markets for publicly traded securities have been volatile and may not continue at all.
- Publicly traded securities are subject to potential delisting from the Nasdaq Global Market.
- If securities or industry analysts cease publishing research or reports, the price and trading volume of Common Stock could decline.
- DeSPAC Public Warrants or deSPAC Private Placement Warrants may expire worthless.
- The company may redeem unexpired deSPAC Warrants prior to their exercise at a time that is disadvantageous to deSPAC Warrant holders.
- DeSPAC Warrants are exercisable for Common Stock, and their exercise would increase the number of shares eligible for future resale and result in dilution.
- 2024 Warrants are exercisable for Common Stock, and their exercise would increase the number of shares eligible for future resale and result in dilution.
- Anti-takeover provisions contained in the Charter and Bylaws, as well as Delaware law, could impair a takeover attempt.
- Bylaws provide that the Court of Chancery of the State of Delaware will be the sole and exclusive forum for certain stockholder litigation matters.
- As an 'emerging growth company' under the JOBS Act, the company takes advantage of certain exemptions from reporting requirements, which may make its Common Stock less attractive to some investors.
Future Outlook
The company expects to continue commercialization efforts, internal testing, and customer trials for its products throughout 2026. It intends to use existing cash to enhance products, conduct R&D, pursue marketing and sales, and fund operations, aiming to achieve revenue from products and services. The company believes it has sufficient liquidity for at least the next 12 months but may seek additional financing opportunistically. Future capital requirements are uncertain and depend on product development pace, commercialization success, and market acceptance. The company also expects to incur significant losses for the foreseeable future as it continues to develop and commercialize its products and build out its sales and marketing capabilities.
Management Comments
- We have never declared or paid any cash dividends on our capital stock, and we do not currently intend to pay any cash dividends on our capital stock in the foreseeable future. We currently intend to retain all available funds and any future earnings to support operations and to finance the growth and development of our business.
- We believe that our cash, cash equivalents and marketable securities on hand will be sufficient to support operations, working capital and capital expenditure requirements for at least the next 12 months from the date of this Report.
- We intend to continue monitoring our liquidity, financial and business results and outlook and market conditions, and may be opportunistic and raise capital when we consider market conditions are good or a favorable opportunity exists.
- We believe that economic advantage is a warfighting advantage and therefore that cost-effective military systems are critical to future military success.
- We believe it is strategically imperative for the United States to build and maintain a strong domestic supply chain for its military needs, from raw materials and manufacturing capability to cutting-edge technologies.
- We believe that our ability to operate 'on the edge' without the need to access large data sets or connect to the cloud is a key differentiator of our AI/ML Foundational Technology and related products.
Industry Context
StockSavvy.ai notes that Palladyne AI's strategic pivot from hardware to AI software aligns with broader industry trends emphasizing advanced autonomy and AI/ML capabilities. The company is targeting both the rapidly evolving defense market, driven by shifting priorities and demand for cost-effective, AI-enabled systems, and the commercial/industrial market, seeking increased productivity through automation in complex environments. Palladyne AI positions its platform-agnostic software as complementary to existing industrial robotics systems from major players like ABB, Fanuc, and KUKA. In the defense sector, it faces formidable competition from large prime contractors such as Lockheed Martin and Boeing, who are accelerating investments in attritable autonomous systems. The company's 'on the edge' AI processing is presented as a differentiator against traditional cloud-based LLMs. The industry is characterized by rapid technological change and an uncertain regulatory landscape, particularly concerning AI/ML technologies, as evidenced by the EU's AI Act.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Bylaws Amendment | The Bylaws were amended to designate the Court of Chancery of the State of Delaware (or other Delaware state/federal court) as the sole and exclusive forum for certain internal corporate claims, and federal district courts as the exclusive forum for Securities Act claims. | March 18, 2024 | This provision may limit stockholders' ability to choose a favorable judicial forum for disputes, potentially discouraging lawsuits against the company or its directors/officers. It does not waive compliance with federal securities laws for Exchange Act claims. |
| Insider Trading Policy Amendment | The Insider Trading Policy was amended and restated to update guidelines on trading restrictions, prohibited transactions (e.g., short sales, derivatives, pledging, margin accounts), pre-clearance requirements for directors and officers, and exceptions for 10b5-1 trading plans. | October 30, 2024 | Enhances internal controls and compliance with federal and state securities laws, aiming to minimize legal and reputational risk related to insider trading. Imposes stricter rules on covered persons regarding securities transactions. |
Legal Proceedings
- The company is not currently a party to or aware of any proceedings that are believed to have, individually or in the aggregate, a material adverse effect on its business, financial condition, or results of operations.
- Regardless of outcome, litigation can have an adverse impact due to defense and settlement costs, diversion of management resources, and other factors.
Related Party Transactions
- On October 31, 2024, the company's Chief Executive Officer and certain other members of the board of directors purchased 430,105 shares of common stock at $2.20 per share and warrants to purchase up to 430,105 shares of common stock at $0.125 per warrant (2024 Concurrent Private Placement Warrants).
Stakeholder Impact
- Shareholders: Potential for dilution from ongoing equity offerings and warrant exercises. The shift to positive equity and net income (though non-operational) may improve investor confidence, but continued operational losses and cash burn pose risks. Anti-takeover provisions may limit premium offers.
- Employees: Continued investment in R&D and commercialization efforts may create job opportunities, but the company faces intense competition for skilled AI/ML engineers. Stock-based compensation is a key retention tool, but potential stock price volatility and trading restrictions could impact value.
- Customers: The strategic pivot to AI software and integrated solutions aims to provide enhanced functionality and cost-effective systems, particularly in defense and industrial automation. Delays in commercialization or product flaws could lead to dissatisfaction.
- Suppliers: Dependence on a limited set of suppliers, some single or sole source, creates supply chain risk, potentially affecting costs and product availability.
- Creditors: Improved total stockholders' equity and ongoing capital raises enhance the company's financial stability, potentially reducing credit risk, though significant accumulated deficit and operational losses persist.
Next Steps
- Continue commercialization efforts, internal testing, and customer trials for AI/ML software, avionics, and UAV products throughout 2026.
- Further enhance and update products, including debugging and stabilizing improvements, and develop next versions of products.
- Invest in sales and marketing efforts to grow the customer base and increase brand awareness.
- Monitor liquidity, financial, and business results and outlook, and market conditions, potentially raising additional capital opportunistically.
- Continue to identify and respond to rapidly evolving customer requirements and competitive threats.
- Integrate the operations, control processes, and information systems of the 2025 acquired companies (GuideTech, MKR Fabricators, Warnke Precision Machining).
Key Dates
| Date | Description |
|---|---|
| January 14, 2021 | Rotor Acquisition Corp. (predecessor) effected a stock dividend of 0.2 shares for each outstanding share of Class B common stock, resulting in 6,900,000 Founder Shares outstanding. |
| January 20, 2021 | Rotor consummated its initial public offering (IPO) of 27,600,000 units and simultaneously sold 7,270,000 deSPAC Private Placement Warrants. |
| April 5, 2021 | Agreement and Plan of Merger signed between Rotor, Rotor Merger Sub Corp., and Sarcos Corp. (Old Sarcos). |
| August 28, 2021 | Amendment No. 1 to the Agreement and Plan of Merger was signed. |
| September 24, 2021 | Business combination between Rotor and Old Sarcos was effected, with Rotor changing its name to Sarcos Technology and Robotics Corporation. deSPAC Warrants became exercisable commencing January 20, 2022. |
| April 2022 | Acquired RE2, Inc., a Pittsburgh, Pennsylvania-based robotics company. |
| July 5, 2023 | A 1-for-6 reverse stock split was effective. |
| November 14, 2023 | Announced a pivot in business strategy to prioritize the development and commercialization of AI/ML Foundational Technology and suspend further commercialization efforts on hardware robotics products. |
| March 18, 2024 | Company changed its name to Palladyne AI Corp. to reflect its new focus. |
| April 17, 2024 | Amended certain stock options, reducing the per share exercise price to $1.59 and restarting vesting schedules for some senior employees. |
| October 30, 2024 | Amended and Restated Insider Trading Policy was adopted. |
| October 31, 2024 | Closed a registered direct offering for 2,790,700 shares of common stock and issued 2,790,700 2024 Private Placement Warrants. Also, the CEO and certain board members purchased 430,105 shares and 430,105 2024 Concurrent Private Placement Warrants. |
| November 1, 2024 | Issued 2024 Warrants, exercisable commencing six months from this date and expiring five and one-half years following this date. |
| November 13, 2024 | Entered into an open market sale agreement with Jefferies LLC for an 'at-the-market' equity offering program, and filed a prospectus supplement for up to $18.0 million of shares. |
| December 15, 2024 | Effective date of the 2024 Inducement Equity Incentive Plan. |
| December 2024 | Offerings under the 2021 Employee Stock Purchase Plan commenced. |
| December 26, 2024 | Amended and Restated Employment Agreement with Benjamin G. Wolff was signed. |
| December 31, 2024 | All shares offered under the $18.0 million 'at-the-market' equity offering program were sold. A prospectus supplement was filed for an additional $30.0 million of shares under the Sales Agreement. |
| May 9, 2025 | 2,790,700 of the 2024 Private Placement Warrants were exercised. |
| July 4, 2025 | The United States enacted tax legislation commonly referred to as the One Big Beautiful Bill Act (OBBBA). |
| August 6, 2025 | Filed a prospectus supplement for an additional $50.0 million of shares under the 'at-the-market' equity offering program. |
| September 24, 2025 | 2,343,750 Earn-Out Shares expired without being released as the stock price target was not met. |
| November 14, 2025 | Acquired GuideTech, LLC, MKR Fabrication, LLC, and Warnke Precision Machining, LLC. |
| December 31, 2025 | Fiscal year end. All shares under the $30.0 million ATM offering were sold. 1,307,852 shares were sold under the August 2025 Prospectus Supplement for gross proceeds of approximately $7.5 million. |
| January 1, 2026 | Through the filing date, 368,326 shares of Common Stock were sold under the 'at-the-market' equity offering program for gross proceeds of $2.5 million. |
| January 5, 2026 | The OECD announced a side-by-side elective safe harbor for U.S.-parented multinationals from certain global minimum tax initiative provisions for fiscal years beginning on or after this date. |
| February 3, 2026 | Company had approximately 161 full-time and part-time employees. |
| February 20, 2026 | Company had 46,494,865 shares of Common Stock outstanding. |
| March 5, 2026 | Date of the Annual Report on Form 10-K filing. |
| August 2, 2026 | European Union's Artificial Intelligence Act (AI Act) is scheduled to become effective over time through this date. |
| September 24, 2026 | deSPAC Warrants will expire. The remaining 2,343,750 Earn-Out Shares will become payable if the closing share price of Common Stock equals or exceeds $120.00 for 20 trading days in any 30 consecutive trading-day period ending on this date. |
| December 31, 2026 | Earliest date the company will cease to be an 'emerging growth company' under the JOBS Act. |
| May 2033 | Lease for the Salt Lake City, Utah facility expires. |
| 2035 | Lease for the Oxford, Michigan machining facility expires. |
| 2035-2037 | Federal net operating loss carryforwards generated between 2015 and 2017 will expire if not utilized. |
| 2037-2045 | Range of expiration dates for many of the company's previously issued patents. |
Recommendation
holdPalladyne AI is undergoing a significant strategic pivot towards AI software and integrated defense/commercial solutions, supported by recent acquisitions and substantial capital raises. While these moves provide a clearer path for future growth and ensure liquidity for the next 12 months, the core operational metrics show a decline in revenue and an increase in operating losses and cash burn. The reported net income is primarily due to non-cash gains from warrant revaluation and a tax benefit from acquisitions, not underlying operational profitability. The commercialization of its new AI products is still in early stages with unproven market demand and long sales cycles. This presents a high-risk, high-reward scenario where the long-term potential is significant if the strategic pivot succeeds, but the near-term operational challenges and reliance on external financing warrant caution. Existing investors should hold, awaiting clearer signs of operational turnaround and successful commercialization.
Keywords
AI software, Artificial Intelligence, Machine Learning, Autonomy solutions, UAVs, Drones, Robotics, Defense technology, Commercial automation, Industrial automation, Palladyne IQ, SwarmOS, Palladyne Pilot, BRAIN Avionics, IntelliSwarm, Gremlin-X, SwarmStrike, SEC filing, 10-K, Financial results, Corporate governance, Risk factors, Capital raise, Acquisitions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.